Amey Moeggenborg
Physician Assistant · West Branch, MINPI 1457399446
Payments from drug & device makers
Across 164 payments — averaging $15.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$689
- AstraZeneca$206
- Lilly USA, LLC$197
- AbbVie$183
- GSK$138
- Lundbeck LLC$133
- plus $949 from 20 others
What the payments were for
- Food & beverage$2,495100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 49 | $689 |
| AstraZeneca | 9 | $206 |
| Lilly USA, LLC | 14 | $197 |
| AbbVie | 11 | $183 |
| GSK | 17 | $138 |
| Lundbeck LLC | 8 | $133 |
| Novartis | 8 | $129 |
| Johnson & Johnson | 4 | $94 |
| Amgen | 6 | $88 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| Astellas Pharma US Inc | 3 | $64 |
| Bayer | 4 | $57 |
| Corium, LLC | 2 | $48 |
| Mylan Specialty L.p. | 3 | $46 |
| Boehringer Ingelheim | 3 | $40 |
| Pfizer | 3 | $38 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Neurelis, Inc. | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$2,495 in reported general payments places this provider in the 85th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 70 | $126,082 |
| EliquisApixaban | 114 | $122,977 |
| JardianceEmpagliflozin | 68 | $104,393 |
| MounjaroTirzepatide | 97 | $103,066 |
| TrulicityDulaglutide | 49 | $84,082 |
| XareltoRivaroxaban | 45 | $67,288 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 81 | $65,937 |
| FarxigaDapagliflozin Propanediol | 38 | $55,544 |
| RybelsusSemaglutide | 26 | $50,754 |
| RexultiBrexpiprazole | 13 | $27,012 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 20 | $22,357 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $16,443 |
| MyrbetriqMirabegron | 17 | $16,319 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $15,065 |
| TrintellixVortioxetine Hydrobromide | 16 | $12,101 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $197 | $187,148146 claims |
| Novo NordiskOzempic, Rybelsus | $689 | $176,83696 claims |
| PfizerEliquis | $38 | $122,977114 claims |
| Boehringer IngelheimJardiance | $40 | $104,39368 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $138 | $88,295101 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $206 | $70,60861 claims |
| Johnson & JohnsonXarelto | $94 | $67,28845 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $68 | $27,01213 claims |
| Astellas Pharma US IncMyrbetriq | $64 | $16,31917 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $69 | $12,10116 claims |
| AbbVieSynthroid | $183 | $2,17325 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in West Branch
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
- Gabrielle DamoreRoyal Oak$200K
- Melissa MickelsonKalamazoo$168K
- Patrick CooneyNew Baltimore$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.